share_log

亨迪药业(301211.SZ):已取得化学原料药克拉屈滨的CEP证书,目前已在欧洲有销售

Hengdi Pharma (301211.SZ): has obtained the CEP certificate of Kroquatine as active pharmaceutical ingredient, and now it is sold in Europe.

Gelonghui Finance ·  Aug 5 03:28

Hengdi Pharmaceutical (301211.SZ) announced on the investor interactive platform on August 5 that the company has obtained the CEP certificate for the chemical raw material Klarqubin, which is currently being sold in Europe. The international active pharmaceutical ingredient business is easily affected by policy changes, overseas market environment changes, exchange rate fluctuations, and other factors. The impact of Klarqubin's CEP certificate on the company's operations and performance remains uncertain. Investors are advised to make cautious decisions and pay attention to investment risks.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment